Profile data is unavailable for this security.
About the company
SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.
- Revenue in INR (TTM)13.75bn
- Net income in INR-1.29bn
- Incorporated1985
- Employees478.00
- LocationSeQuent Scientific Ltd301/A, 3rd Floor,Dosti Pinnacle,, Plot No.E7,Road No. 22MUMBAI 400604IndiaIND
- Phone+91 2 241114777
- Fax+91 2 241114754
- Websitehttps://sequent.in/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amrutanjan Health Care Ltd | 3.94bn | 440.09m | 19.92bn | 575.00 | 45.58 | -- | 39.97 | 5.05 | 15.13 | 15.13 | 135.41 | -- | -- | -- | -- | 6,860,612.00 | -- | 17.04 | -- | 21.22 | 49.51 | 54.08 | 11.16 | 13.37 | -- | 341.76 | -- | 17.21 | -6.46 | 11.37 | -40.71 | 14.72 | 23.87 | 10.64 |
| Solara Active Pharma Sciences Ltd | 14.07bn | -3.08bn | 20.19bn | 2.36k | -- | -- | -- | 1.43 | -85.65 | -85.65 | 390.73 | -- | -- | -- | -- | 5,958,916.00 | -- | 2.68 | -- | 4.10 | 40.47 | 44.49 | -21.88 | 4.58 | -- | -1.67 | -- | 10.10 | 13.83 | 22.61 | 61.86 | -- | 26.23 | -- |
| Suven Life Sciences Ltd | 119.19m | -1.06bn | 24.77bn | 132.00 | -- | -- | -- | 207.85 | -5.20 | -5.20 | 0.5759 | -- | -- | -- | -- | 902,939.40 | -- | -31.29 | -- | -35.32 | -- | 66.93 | -890.87 | -127.02 | -- | -744.27 | -- | -- | 14.31 | -53.54 | 3.06 | -- | -41.37 | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 25.19bn | 1.23k | -- | 79.68 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
| Morepen Laboratories Ltd | 16.31bn | 761.19m | 25.58bn | 1.65k | 33.16 | -- | 23.92 | 1.57 | 1.51 | 1.51 | 32.53 | -- | -- | -- | -- | 9,891,111.00 | -- | 7.39 | -- | 13.78 | 35.85 | 32.82 | 4.67 | 5.19 | -- | 27.34 | -- | 0.00 | -8.36 | 18.51 | -61.96 | 5.50 | 11.33 | -- |
| RPG Life Sciences Limited | 5.74bn | 847.70m | 25.61bn | 1.17k | 30.22 | -- | 25.30 | 4.47 | 51.26 | 51.26 | 346.80 | -- | -- | -- | -- | -- | -- | 13.08 | -- | 18.26 | 68.17 | 62.42 | 14.78 | 9.71 | -- | 296.86 | -- | 29.26 | 16.51 | 8.12 | 31.39 | 38.13 | 16.15 | 37.97 |
| Innova Captab Ltd | -100.00bn | -100.00bn | 27.01bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 15.72 | -- | 6.26 | -- | -- | -- |
| Indoco Remedies Ltd | 17.96bn | 1.02bn | 29.87bn | 6.10k | 29.65 | -- | 16.23 | 1.66 | 10.93 | 10.93 | 192.26 | -- | -- | -- | -- | 2,943,454.00 | -- | 6.07 | -- | 8.90 | 69.39 | 65.35 | 5.61 | 6.30 | -- | 5.11 | -- | 14.79 | 8.30 | 9.81 | -8.11 | 28.15 | 8.25 | 17.61 |
| SeQuent Scientific Ltd | 13.75bn | -1.29bn | 31.12bn | 478.00 | -- | -- | -- | 2.26 | -5.18 | -5.18 | 55.33 | -- | -- | -- | -- | 28,769,920.00 | -- | 2.33 | -- | 3.67 | 42.78 | 42.47 | -8.97 | 2.59 | -- | -0.3894 | -- | 17.27 | 0.5728 | 10.84 | -395.83 | -- | 12.88 | -- |
| Gufic BioSciences Ltd | 7.85bn | 841.95m | 32.16bn | 1.63k | 37.20 | -- | 30.49 | 4.10 | 8.62 | 8.62 | 80.38 | -- | -- | -- | -- | 4,820,074.00 | -- | 12.30 | -- | 23.08 | 51.08 | 44.91 | 10.73 | 9.84 | -- | 8.22 | -- | 1.39 | -11.36 | 17.47 | -16.84 | 37.06 | 86.82 | 14.87 |
| Supriya Lifescience Ltd | 5.54bn | 1.20bn | 33.30bn | 392.00 | 27.64 | -- | 24.61 | 6.01 | 14.97 | 14.97 | 68.93 | -- | -- | -- | -- | 14,144,410.00 | -- | 20.77 | -- | 29.06 | 61.94 | 55.83 | 21.72 | 24.33 | -- | 63.63 | -- | 2.02 | -13.04 | 16.70 | -40.81 | 59.41 | 85.55 | -- |
| Dishman Carbogen Amcis Ltd | 25.80bn | -1.54bn | 36.59bn | 1.30k | -- | -- | 24.83 | 1.42 | -9.84 | -9.84 | 164.35 | -- | -- | -- | -- | 19,919,850.00 | -- | 0.4699 | -- | 0.5665 | 76.93 | 74.36 | -5.98 | 1.82 | -- | -0.1245 | -- | 202.76 | 12.72 | 7.32 | -265.46 | -- | 21.54 | -- |
| Hikal Ltd | 18.16bn | 716.22m | 38.06bn | 2.14k | 53.18 | -- | 20.71 | 2.10 | 5.80 | 5.80 | 147.17 | -- | -- | -- | -- | 8,477,077.00 | -- | 5.86 | -- | 8.87 | 52.08 | 45.41 | 3.94 | 6.37 | -- | 2.78 | -- | 10.14 | 4.13 | 9.25 | -51.16 | 0.2973 | 23.35 | 4.42 |
| Unichem Laboratories Ltd | 16.75bn | 145.69m | 40.87bn | 3.12k | 280.93 | -- | 31.36 | 2.44 | 2.07 | 2.07 | 234.69 | -- | -- | -- | -- | 5,364,373.00 | -- | -1.38 | -- | -1.66 | 59.94 | 56.15 | 0.8696 | -3.60 | -- | -0.9613 | -- | -- | 5.76 | 10.51 | -711.67 | -- | -22.60 | -- |
Data as of Apr 26 2024. Currency figures normalised to SeQuent Scientific Ltd's reporting currency: Indian Rupee INR
11.80%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| quant Money Managers Ltd.as of 31 Mar 2024 | 11.94m | 4.79% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 30 Jun 2023 | 8.31m | 3.33% |
| White Oak Capital Partners Pte Ltd.as of 30 Jun 2023 | 4.08m | 1.64% |
| The Public Sector Pension Investment Boardas of 30 Jun 2023 | 2.66m | 1.07% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 1.27m | 0.51% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 825.69k | 0.33% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Mar 2024 | 176.89k | 0.07% |
| ITI Asset Management Ltd. (India)as of 31 Mar 2024 | 124.34k | 0.05% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 32.67k | 0.01% |
| American Century Investment Management, Inc.as of 04 Apr 2024 | 4.92k | 0.00% |
More ▼
Data from 30 Jun 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
